Skip to main content
Changchun Bcht Biotechnology Co. logo

Changchun Bcht Biotechnology Co. — Investor Relations & Filings

Ticker · 688276 ISIN · CNE100005XY6 LEI · 8368000E14LIZR0C4328 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2024-11-22 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688276

About Changchun Bcht Biotechnology Co.

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co. is a biopharmaceutical enterprise focused on the research, development, production, and marketing of human vaccines. The company specializes in preventing infectious diseases through innovative biological products. Its primary product portfolio includes the Varicella Vaccine (Live), which maintains a significant market presence, and the Influenza Vaccine (Live, Nasal, Freeze-dried). Additionally, the company produces the Rabies Vaccine for human use and has expanded its pipeline to include a Herpes Zoster vaccine. BCHT Biotechnology emphasizes technological innovation, utilizing advanced platforms for viral culture and purification to ensure product safety and efficacy. The company operates large-scale manufacturing facilities designed to meet international quality standards, aiming to address public health needs through a diverse range of immunization solutions.

Recent filings

Filing Released Lang Actions
长春百克生物科技股份公司对外投资管理制度
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' which translates to 'External Investment Management System' and details the company's policies, organizational structure, approval procedures, implementation, management, financial management, audit, reporting, and disclosure related to external investments. It is a comprehensive internal policy document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a regulatory filing or announcement of a report but a governance-related document outlining internal rules and procedures for investment management. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and the content is detailed, supporting a high confidence classification.
2024-11-22 Chinese
长春百克生物科技股份公司关于选举第六届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board. It includes details about the election process, compliance with relevant laws and regulations, and a biography of the elected individual. There is no financial data, no mention of financial results, no report publication, and no regulatory certification. The content focuses on board/management information, specifically about the supervisory board composition and election. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2024-11-22 Chinese
长春百克生物科技股份公司股东会议事规则
Governance Information Classification · 95% confidence The document is titled as "股东会议事规则" which translates to "Shareholders Meeting Rules" or "Rules of Procedure for Shareholders' Meetings". The content extensively details the procedures, rights, and obligations related to shareholders' meetings, including the convening, notification, proposal submission, voting, and resolutions of shareholders' meetings. It does not contain financial statements, audit opinions, or earnings data. It is a governance document outlining internal rules and procedures for shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length is substantial and it is not an announcement or a brief notice, so it is not a report publication announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2024-11-22 Chinese
独立董事候选人声明与承诺（施维）
Regulatory Filings
2024-11-22 Chinese
长春百克生物科技股份公司简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the shareholding changes of an individual shareholder (魏学宁) in 长春百克生物科技股份公司, including the reduction of shareholding to 5%. The document references relevant securities laws and regulations, discloses the nature and timing of share transactions, and includes declarations and legal statements by the shareholder. There is no indication of it being an annual report, earnings release, or other financial report. Instead, it is a formal notification of a change in major shareholding. This fits the definition of a Major Shareholding Notification (MRQ). The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2024-11-06 Chinese
长春百克生物科技股份公司关于持股5%以上股东权益变动至5%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a change in shareholding by a shareholder who held more than 5% of the company's shares but has reduced their stake to exactly 5%. It details the shareholder's name, the number of shares held before and after the change, the method of share reduction, and confirms that this change does not affect control of the company. The document references compliance with securities laws and disclosure obligations. There is no financial data, earnings information, or management discussion. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds such as 5%. The document length is short (2181 characters), and it is not an announcement of a report publication but the actual notification of shareholding change. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2024-11-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.